(Q47775625)

5 February 2018

review article

1 reference

title

Functions of the von Hippel-Lindau tumour suppressor protein. (English)

1 reference

5 February 2018

1

Kaelin WG

1 reference

5 February 2018

Iliopoulos O

2

1 reference

5 February 2018

Lonergan KM

series ordinal

3

1 reference

5 February 2018

Ohh M

series ordinal

4

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

5 February 2018

Journal of Internal Medicine

published in

1 reference

5 February 2018

volume

243

1 reference

5 February 2018

page(s)

535-539

1 reference

5 February 2018

issue

6

1 reference

5 February 2018

Identification of the von Hippel-Lindau disease tumor suppressor gene

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Isolation and characterization of the full-length 3' untranslated region of the human von Hippel-Lindau tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Tumour suppression by the human von Hippel-Lindau gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Von Hippel-Lindau tumour suppressor gene. Localization of expression by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Lessons from hereditary colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Inhibition of transcription elongation by the VHL tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Polycythemia: mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Cell cycle: cull and destroy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Fibronectin and the pericellular matrix of normal and transformed adherent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Modulation of cell surface glycocalyx: studies on large, external, transformation-sensitive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

A large glycoprotein lost from the surfaces of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Glycoprotein-containing factor that mediates contact inhibition of growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

A polymeric form of fibronectin has antimetastatic effects against multiple tumor types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.1998.00335.X

Immunostaining of the von Hippel-Lindau gene product in normal and neoplastic human tissues

21 January 2018

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1365-2796.1998.00335.X

Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1365-2796.1998.00335.X

Frequent overexpression of vascular endothelial growth factor gene in human renal cell carcinoma

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1046/J.1365-2796.1998.00335.X

Identifiers

DOI

10.1046/J.1365-2796.1998.00335.X

1 reference

5 February 2018

PubMed ID

9681855

1 reference

5 February 2018